
    
      Study design: open-labeled, controlled, parallel group, non-interventional 3-weeks-study with
      followed prospective observation during 1 week and 1 year follow-up period.

      Patients of group I take the probiotic Mutaflor orally in the dose 1 ml once a day during
      first week of life and three times per week during the second and third week of life.
      Patients of the group II don't take specific probiotic for immunity strengthening.
    
  